How should a 12-year-old with acute sinusitis be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Bacterial Sinusitis in a 12-Year-Old

Start oral amoxicillin 45 mg/kg/day divided twice daily for 10–14 days (or until symptom-free for 7 days) as first-line therapy. 1

Diagnostic Confirmation

The diagnosis is entirely clinical—do not obtain imaging studies (X-rays or CT scans) for uncomplicated cases, as they do not change management and lack specificity. 1, 2

  • A 12-year-old meets criteria for acute bacterial sinusitis if presenting with any of these three patterns: 1
    • Persistent illness: nasal discharge (any quality) or daytime cough lasting >10 days without improvement 1
    • Worsening course: sudden worsening or new fever ≥38°C after initial improvement 1
    • Severe onset: fever ≥39°C plus purulent nasal discharge for ≥3 consecutive days 1

First-Line Antibiotic Regimen

  • Standard-dose amoxicillin (45 mg/kg/day divided twice daily) is the recommended first-line agent for uncomplicated acute bacterial sinusitis. 1, 2

  • The number needed to treat with antibiotics is 3–5 to achieve clinical cure, demonstrating substantial benefit over observation. 1, 2

  • Treatment duration should be 10–14 days total, or continue until the child is symptom-free for at least 7 days. 2, 3

When to Escalate to High-Dose Therapy

Use high-dose amoxicillin (80–90 mg/kg/day) or high-dose amoxicillin-clavulanate if the child has any of these risk factors: 1, 2

  • Recent antibiotic use within the past 4–6 weeks 1, 2
  • Daycare attendance 1, 2
  • Residence in areas with high prevalence of penicillin-resistant Streptococcus pneumoniae 1, 2
  • Age <2 years (not applicable to this 12-year-old) 2

Mandatory 72-Hour Reassessment

Re-evaluate the child exactly 72 hours after starting amoxicillin to identify treatment failure or complications: 1, 2, 4

  • Worsening symptoms (new fever, increased purulent discharge, severe headache) → escalate immediately to high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component). 1, 2, 5

  • Lack of improvement by 72 hours → consider escalation to high-dose amoxicillin-clavulanate. 2, 4

  • Orbital complications (periorbital swelling, proptosis, impaired eye movements) → obtain immediate contrast-enhanced CT and specialist consultation. 1, 2, 4

  • Intracranial complications (altered mental status, severe headache, focal neurologic deficits, seizures) → emergent CT and neurosurgical evaluation. 2, 4

Alternative Antibiotics for Penicillin Allergy

If the child has a documented penicillin allergy, use one of these alternatives: 6, 5

  • Cefdinir 14 mg/kg once daily (or 7 mg/kg twice daily) for 10 days 7, 5
  • Cefpodoxime or cefuroxime 6, 5
  • Second- and third-generation cephalosporins carry minimal cross-reactivity risk even in penicillin-allergic patients. 6

Parenteral Option for Non-Adherence or Vomiting

  • If the child cannot tolerate oral medication or adherence is unlikely, give ceftriaxone 50 mg/kg (maximum 2 grams) as a single intramuscular or intravenous dose. 6

  • If clinical improvement occurs within 24 hours, switch to oral high-dose amoxicillin-clavulanate to complete the 10–14 day course. 6

  • If the child remains significantly febrile or symptomatic at 24 hours, additional parenteral ceftriaxone doses may be required before transitioning to oral therapy. 6

Microbiologic Rationale

The three major pathogens in pediatric acute bacterial sinusitis are: 1, 2

  • Streptococcus pneumoniae (~30%) 1, 2
  • Nontypeable Haemophilus influenzae (~20–30%) 1, 5
  • Moraxella catarrhalis (~10–20%) 1, 5

Approximately 10–15% of S. pneumoniae isolates are penicillin-nonsusceptible, and 10–42% of H. influenzae and nearly 100% of M. catarrhalis produce β-lactamase, justifying escalation to amoxicillin-clavulanate in treatment failures. 6

Common Pitfalls to Avoid

  • Do not delay antibiotic therapy once the diagnosis is confirmed; although the AAP permits a 3-day observation period for persistent cases, this option is only appropriate at exactly 10 days of symptoms, not for severe or worsening presentations. 1, 2

  • Do not obtain sinus imaging in uncomplicated cases—imaging is reserved exclusively for suspected orbital or intracranial complications. 1, 2

  • Do not prescribe trimethoprim-sulfamethoxazole or azithromycin due to high resistance rates among common pathogens. 6

  • Do not use antihistamines or decongestants as primary treatment, as randomized trials show no incremental benefit when added to antibiotics. 8

  • Do not start with amoxicillin-clavulanate unless risk factors for resistant organisms are present; standard amoxicillin remains first-line for uncomplicated disease. 2, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Acute Bacterial Sinusitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Management of acute bacterial rhinosinusitis.

Current opinion in pediatrics, 2002

Guideline

Management of Bacterial Sinusitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Dosing for Pediatric Sinusitis and Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.